COMPASS
COMPASS
(Customised Oncology through Molecular Profiling and Strategic Selection)
Charting the Future of Precision Oncology
The COMPASS theme unites a diverse community of basic and clinical cancer scientists to advance customised oncology. By integrating molecular profiling for strategic patient selection and enabling technologies for new treatment modalities, COMPASS builds a collaborative platform to discover mechanisms, refine therapies and accelerate precision medicine with a focus on Asian-specific tumour types.
Advancing Precision Oncology from Innovation to Clinical Impact
The COMPASS theme is a strategically designed framework to advance precision oncology at N2CR. It integrates clinical implementation, discovery science, grant optimisation, and community engagement into a cohesive pipeline. Ultimately, this theme aims to drive molecular diagnostics, AI-driven analytics, and/or medtech innovations to develop cost-effective, implementable strategies and identify the next major targets or mechanisms in oncology.
Theme Leads
Dr TAY Kai Xun, Joshua
